Drug Profile
Insulin transdermal - Transdermal Global
Alternative Names: U-strip; U-Strip™ insulin patch; U-Strip™-insulinLatest Information Update: 21 Jan 2022
Price :
$50
*
At a glance
- Originator Dermisonics; Encapsulation Systems
- Developer Transdermal Global
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Type-1 diabetes mellitus in USA (Transdermal, Patch)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Type-2-diabetes-mellitus in USA (Transdermal, Patch)
- 31 May 2012 Phase-I development is ongoing with Transdermal Specialties for Diabetes mellitus in the USA